Edgewise Historical Financial Ratios
| EWTX Stock | USD 32.20 0.12 0.37% |
Edgewise Therapeutics is recently reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.3 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Edgewise Therapeutics financial condition quickly.
Edgewise |
About Edgewise Financial Ratios Analysis
Edgewise TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Edgewise Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Edgewise financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Edgewise Therapeutics history.
Edgewise Therapeutics Financial Ratios Chart
Add Fundamental
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from Edgewise Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Edgewise Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.At this time, Edgewise Therapeutics' Ebt Per Ebit is fairly stable compared to the past year. Effective Tax Rate is likely to rise to 0.20 in 2024, whereas Book Value Per Share is likely to drop 2.56 in 2024.
Edgewise Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Edgewise Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edgewise Stock Analysis
When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.